Literature DB >> 26267748

Elevated serum fibrinogen levels and risk of contrast-induced acute kidney injury in patients undergoing a percutaneous coronary intervention for the treatment of acute coronary syndrome.

Ibrahim E Celik1, Alparslan Kurtul, Mustafa Duran, Mikail Yarlioglues, Deniz Elcik, Alparslan Kilic, Cemal Koseoglu, Fatih Oksuz, Sani N Murat.   

Abstract

OBJECTIVES: Contrast-induced acute kidney injury (CI-AKI) is a common complication of diagnostic and therapeutic catheterizations, especially in the setting of acute coronary syndrome (ACS). Fibrinogen is a well-known cardiovascular risk factor. We evaluated whether serum fibrinogen level is associated independently with CI-AKI in patients with ACS who underwent a percutaneous coronary intervention (PCI).
METHODS: Patients (n=710, aged 61 ± 13, 69% men) were classified into two groups: CI-AKI and non-CI-AKI. CI-AKI was defined as an increase of at least 0.5 mg/dl or at least 25% in the serum creatinine level within 72 h following PCI.
RESULTS: CI-AKI occurred in 75 (10.6%) patients. We found significantly higher serum fibrinogen levels in patients who developed CI-AKI than in those who did not (498 ± 152 vs. 386 ± 96 mg/dl, P<0.001). Multivariate logistic regression analysis showed that serum fibrinogen level (odds ratio 1.006, 95% confidence interval 1.003-1.009, P<0.001), age, glomerular filtration rate, female sex, and white blood cell count were correlated with the development of CI-AKI.
CONCLUSION: Serum fibrinogen level is associated independently with a higher risk of CI-AKI in patients with ACS undergoing PCI.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26267748     DOI: 10.1097/MCA.0000000000000295

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  8 in total

1.  Predictive value of combining the level of fibrinogen and CHA2DS2-VASC Score for contrast-induced acute kidney injury in patients with acute coronary syndromes undergoing percutaneous coronary intervention.

Authors:  Jing Li; Zhen Wang; BaiXiang Zhang; Di Zheng; Yuan Lu; Wenhua Li
Journal:  Int Urol Nephrol       Date:  2022-02-19       Impact factor: 2.266

2.  Prognostic value of fibrinogen to albumin ratios among critically ill patients with acute kidney injury.

Authors:  Wenkai Xia; Chenyu Li; Xiajuan Yao; Yan Chen; Yaoquan Zhang; Hong Hu
Journal:  Intern Emerg Med       Date:  2021-11-30       Impact factor: 5.472

3.  Elevated serum fibrinogen level is an independent risk factor for IgA nephropathy.

Authors:  Ji Zhang; Chaosheng Chen; Qiongxiu Zhou; Shubei Zheng; Yinqiu Lv; Jianna Zhang; Xiaohan You; Zhanyuan Li; Zhihong Zhou; Min Pan
Journal:  Oncotarget       Date:  2017-10-09

4.  Effect of Serum Netrin-1 Levels on Diagnosis and Prognosis in Patients Admitted to the Emergency Service for Acute Coronary Syndrome.

Authors:  Huseyin Mutlu; Nazire Akilli; Basar Cander; Öznur Köylü; Murat Gul; Ramazan Köylü
Journal:  Cureus       Date:  2020-04-20

5.  Predictive Value of Fibrinogen-to-Albumin Ratio for Post-Contrast Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention.

Authors:  Can Wang; Gaoye Li; Xiaomei Liang; Chunyu Qin; Qiuhu Luo; Rui Song; Wuxian Chen
Journal:  Med Sci Monit       Date:  2020-07-20

Review 6.  From Classic to Modern Prognostic Biomarkers in Patients with Acute Myocardial Infarction.

Authors:  Cristian Stătescu; Larisa Anghel; Bogdan-Sorin Tudurachi; Andreea Leonte; Laura-Cătălina Benchea; Radu-Andy Sascău
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

7.  Preoperative Serum Fibrinogen is Associated With Acute Kidney Injury after Cardiac Valve Replacement Surgery.

Authors:  Jing Juan Yang; Wen Hua Lei; Peng Hu; Bin Bin Wu; Jian Xiao Chen; Yi Ming Ni; En Yin Lai; Fei Han; Jiang Hua Chen; Yi Yang
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

8.  Fibrinogen-to-Albumin Ratio Predicts Contrast-Induced Nephropathy in Patients after Emergency Percutaneous Coronary Intervention.

Authors:  Zhebin You; Tailin Guo; Fan Lin; Chunjin Lin; Jiankang Chen; Xiaoming Li; Yan Chen; Kaiyang Lin
Journal:  Cardiol Res Pract       Date:  2019-11-11       Impact factor: 1.866

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.